Wangrui Liu

1.5k total citations
66 papers, 1.0k citations indexed

About

Wangrui Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Wangrui Liu has authored 66 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 30 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in Wangrui Liu's work include Ferroptosis and cancer prognosis (27 papers), Renal cell carcinoma treatment (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Wangrui Liu is often cited by papers focused on Ferroptosis and cancer prognosis (27 papers), Renal cell carcinoma treatment (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Wangrui Liu collaborates with scholars based in China, United States and United Kingdom. Wangrui Liu's co-authors include Wenhao Xu, Aihetaimujiang Anwaier, Xi Tian, Yuanyuan Qu, Dingwei Ye, Hailiang Zhang, Shiyin Wei, Jiaqi Su, Jing Teng and Guohai Shi and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and Immunological Reviews.

In The Last Decade

Wangrui Liu

61 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wangrui Liu China 19 470 351 300 279 232 66 1.0k
Marcin Braun Poland 13 568 1.2× 225 0.6× 296 1.0× 297 1.1× 68 0.3× 88 1.1k
Wenhao Xu China 23 880 1.9× 727 2.1× 574 1.9× 403 1.4× 235 1.0× 124 1.8k
Xijuan Liu China 16 554 1.2× 198 0.6× 286 1.0× 324 1.2× 158 0.7× 42 1.1k
Jianfeng Wang China 22 579 1.2× 433 1.2× 330 1.1× 203 0.7× 129 0.6× 99 1.3k
Jingcheng Zhou China 19 694 1.5× 205 0.6× 517 1.7× 159 0.6× 77 0.3× 69 1.2k
Changying Li China 21 451 1.0× 150 0.4× 333 1.1× 102 0.4× 86 0.4× 44 925
Xuehai Wang China 15 378 0.8× 127 0.4× 195 0.7× 135 0.5× 153 0.7× 60 752
Koji Teramoto Japan 18 338 0.7× 273 0.8× 169 0.6× 502 1.8× 324 1.4× 81 1.1k
Li Xiong China 12 457 1.0× 684 1.9× 386 1.3× 194 0.7× 171 0.7× 32 1.1k
Yongfu Ma China 18 550 1.2× 193 0.5× 475 1.6× 150 0.5× 86 0.4× 44 945

Countries citing papers authored by Wangrui Liu

Since Specialization
Citations

This map shows the geographic impact of Wangrui Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangrui Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangrui Liu more than expected).

Fields of papers citing papers by Wangrui Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangrui Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangrui Liu. The network helps show where Wangrui Liu may publish in the future.

Co-authorship network of co-authors of Wangrui Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Wangrui Liu. A scholar is included among the top collaborators of Wangrui Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangrui Liu. Wangrui Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wangrui, Jiachang Chi, Huaqi Guo, & Wei Guo. (2025). Microplastic Exposure in COPD Alters the Immune Microenvironment: Implications for Tumor-Promoting Inflammation. PA1590–PA1590.
2.
Wang, Jiayu, Zhiqiang Chen, Wangrui Liu, et al.. (2025). Harnessing plant-derived natural compounds to target ferroptosis, pyroptosis, immune modulation and renin-angiotensin system in renal cell carcinoma. Journal of the Renin-Angiotensin-Aldosterone System. 26.
3.
Xu, Wenhao, Xi Tian, Shiqi Ye, et al.. (2024). Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. SHILAP Revista de lepidopterología. 5(1). e461–e461. 27 indexed citations
4.
Li, Tong‐Fei, Zhijie Xu, Kui Zhang, et al.. (2024). Effects and mechanisms of N6-methyladenosine RNA methylation in environmental pollutant-induced carcinogenesis. Ecotoxicology and Environmental Safety. 277. 116372–116372. 4 indexed citations
5.
Liu, Wangrui, Zhilan Liu, Zhe Geng, et al.. (2023). Numerical study on the cooling performance of various arrangements of medium-gap-medium for direct evaporative cooling systems. Applied Thermal Engineering. 236. 121921–121921. 4 indexed citations
6.
Wang, Mingwei, Qi Gao, Zhilan Liu, et al.. (2023). Nozzle arrangement study for pre-cooling the inlet air of natural draft dry cooling tower under crosswinds. International Journal of Refrigeration. 148. 1–12. 11 indexed citations
8.
Ye, Shiqi, Aihetaimujiang Anwaier, Shiyin Wei, et al.. (2023). Protein Arginine Methyltransferases Refine the Classification of Clear Cell Renal Cell Carcinoma with Distinct Prognosis and Tumor Microenvironment Characteristics. International Journal of Biological Sciences. 19(14). 4552–4570. 8 indexed citations
10.
Tian, Xi, Wangrui Liu, Xinrui Wu, et al.. (2023). Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma. Journal of Cancer Research and Clinical Oncology. 149(19). 17451–17466. 2 indexed citations
11.
Chang, Kun, Jiaqi Su, Chuanyu Li, et al.. (2022). Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma. Frontiers in Oncology. 12. 1079446–1079446. 2 indexed citations
12.
Liu, Wangrui, Xinrui Wu, Shiyin Wei, et al.. (2022). Transcriptome Profiles Reveal a 12-Signature Metabolic Prediction Model and a Novel Role of Myo-Inositol Oxygenase in the Progression of Prostate Cancer. Frontiers in Oncology. 12. 899861–899861. 2 indexed citations
13.
Wu, Xinrui, Hui Xiong, Ying Xu, et al.. (2022). Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer. Frontiers in Immunology. 13. 922780–922780. 89 indexed citations
15.
Xu, Wenhao, Aihetaimujiang Anwaier, Wangrui Liu, et al.. (2022). Immunogenomic Characteristics of Cell-Death-Associated Genes with Prognostic Implications in Bladder Cancer. Frontiers in Immunology. 13. 909324–909324. 8 indexed citations
16.
Xu, Wenhao, Aihetaimujiang Anwaier, Wangrui Liu, et al.. (2022). The unique genomic landscape and prognostic mutational signature of Chinese clear cell renal cell carcinoma. SHILAP Revista de lepidopterología. 2(3). 162–170. 10 indexed citations
17.
Xu, Wenhao, Wenkai Zhu, Wangrui Liu, et al.. (2021). Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma. Frontiers in Immunology. 12. 734646–734646. 18 indexed citations
18.
Xu, Wenhao, Wenkai Zhu, Xi Tian, et al.. (2021). Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma. Frontiers in Cell and Developmental Biology. 9. 772436–772436. 8 indexed citations
19.
Xu, Wenhao, Aihetaimujiang Anwaier, Chunguang Ma, et al.. (2021). Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment. Frontiers in Cell and Developmental Biology. 9. 785410–785410. 17 indexed citations
20.
Liu, Wangrui, Wenhao Xu, Yuyan Chen, et al.. (2020). Elevated double-strand break repair protein RAD50 predicts poor prognosis in hepatitis B virus-related hepatocellular carcinoma: A study based on Chinese high-risk cohorts. Journal of Cancer. 11(20). 5941–5952. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026